<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28276062</article-id>
<article-id pub-id-type="pmc">5386840</article-id>
<article-id pub-id-type="doi">10.1111/epi.13709</article-id>
<article-id pub-id-type="manuscript">NIHMS847552</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ILAE Classification of the Epilepsies Position Paper of the ILAE
Commission for Classification and Terminology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Scheffer</surname>
<given-names>Ingrid E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berkovic</surname>
<given-names>Samuel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capovilla</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Connolly</surname>
<given-names>Mary B</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>French</surname>
<given-names>Jacqueline</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guilhoto</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hirsch</surname>
<given-names>Edouard</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jain</surname>
<given-names>Satish</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mathern</surname>
<given-names>Gary W.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moshé</surname>
<given-names>Solomon L</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nordli</surname>
<given-names>Douglas R</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perucca</surname>
<given-names>Emilio</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tomson</surname>
<given-names>Torbjörn</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wiebe</surname>
<given-names>Samuel</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yue-Hua</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zuberi</surname>
<given-names>Sameer M</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Medicine, The University of Melbourne, Austin Health,
Melbourne, Australia</aff>
<aff id="A2"><label>2</label>Department of Paediatrics, The University of Melbourne, Royal
Children’s Hospital, and Florey Institute, Melbourne, Australia</aff>
<aff id="A3"><label>3</label>Epilepsy Center, Child Neuropsychiatry Department, C. Poma Hospital,
Mantova, Italy</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, University of British Columbia, British
Columbia’s Children’s Hospital, Vancouver, Canada</aff>
<aff id="A5"><label>5</label>Department of Neurology, New York University Langone Medical Center,
New York, New York, U.S.A</aff>
<aff id="A6"><label>6</label>Neurology Department of Universidade Federal de São Paulo
and Hospital Universitário da Universidade de São Paulo,
Brazil</aff>
<aff id="A7"><label>7</label>University-Hospital-INSERM U 964-Strasbourg; IDÉE-Lyon;
France</aff>
<aff id="A8"><label>8</label>Indian Epilepsy Centre, New Delhi, India</aff>
<aff id="A9"><label>9</label>Departments of Neurosurgery, Psychiatry and Biobehavioral Medicine,
David Geffen School of Medicine, UCLA, Los Angeles, California, U.S.A</aff>
<aff id="A10"><label>10</label>Saul R. Korey Department of Neurology, Dominic k P. Purpura
Department of Neuroscience and Department of Pediatrics, Albert Einstein College of
Medicine and Montefiore Medical Center, Bronx, New York, U.S.A</aff>
<aff id="A11"><label>11</label>Division of Neurology, Children’s Hospital Los Angeles,
U.S.A</aff>
<aff id="A12"><label>12</label>C. Mondino National Neurological Institute and Clinical
Pharmacology Unit, University of Pavia, Pavia, Italy</aff>
<aff id="A13"><label>13</label>Department of Clinical Neuroscience, Karolinska Institutet,
Stockholm, Sweden</aff>
<aff id="A14"><label>14</label>Departments of Clinical Neurosciences and Community Health
Sciences, University of Calgary, Alberta, Canada</aff>
<aff id="A15"><label>15</label>Department of Pediatrics, Peking University First Hospital, Beijing
100034, China</aff>
<aff id="A16"><label>16</label>Paediatric Neurosciences Research Group, Fraser of Allander
Neurosciences Unit, Royal Hospital for Children, Glasgow, and School of Medicine,
University of Glasgow, United Kingdom</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Prof Ingrid Scheffer, Epilepsy Research
Centre, 245 Burgundy St, Heidelberg, Victoria, 3084, Australia, Ph:
(+613) 9035 7344, Fax: (+613) 9496 2291,
<email>scheffer@unimelb.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>58</volume>
<issue>4</issue>
<fpage>512</fpage>
<lpage>521</lpage>
<!--elocation-id from pubmed: 10.1111/epi.13709-->
<abstract>
<title>Summary</title>
<p id="P2">The ILAE Classification of the Epilepsies has been updated to reflect our
gain in understanding of the epilepsies and their underlying mechanisms
following the major scientific advances which have taken place since the last
ratified classification in 1989. As a critical tool for the practising
clinician, epilepsy classification must be relevant and dynamic to changes in
thinking, yet robust and translatable to all areas of the globe. Its primary
purpose is for diagnosis of patients, but it is also critical for epilepsy
research, development of antiepileptic therapies and communication around the
world. The new classification originates from a draft document submitted for
public comments in 2013 which was revised to incorporate extensive feedback from
the international epilepsy community over several rounds of consultation. It
presents three levels, starting with <italic>seizure type</italic> where it
assumes that the patient is having epileptic seizures as defined by the new 2017
ILAE Seizure Classification. After diagnosis of the <italic>seizure
type</italic>, the next step is diagnosis of <italic>epilepsy type</italic>,
including focal epilepsy, generalized epilepsy, combined generalized and focal
epilepsy, and also an unknown epilepsy group. The third level is that of
<italic>epilepsy syndrome</italic> where a specific syndromic diagnosis can
be made. The new classification incorporates <italic>etiology</italic> along
each stage, emphasizing the need to consider etiology at each step of diagnosis
as it often carries significant treatment implications. Etiology is broken into
six subgroups, selected because of their potential therapeutic consequences. New
terminology is introduced such as developmental and epileptic encephalopathy.
The term benign is replaced by the terms self-limited and pharmacoresponsive, to
be used where appropriate. It is hoped that this new framework will assist in
improving epilepsy care and research in the 21<sup>st</sup> century.</p>
</abstract>
<kwd-group>
<kwd>Classification</kwd>
<kwd>Epilepsy syndromes</kwd>
<kwd>Terminology</kwd>
<kwd>Etiology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>